The Tom Sox have been a part of summers in Charlottesvilles since 2015 when they kicked off their inaugural season at Charlottesville High School. This year HemoShear Therapeutics has added two Tom Sox pitchers to their team as interns.
Our First Partnership! AMPEL Biosolutions and ArcheMedX join forces in a strategic partnership to improve the success rate of clinical trials. This partnership builds on AMPEL’s expertise in clinical operations and ArcheMedX digital platform for online healthcare education to improve patient recruitment and attention.
3rd Annual Spring Biosciences Lunch - Diffusion’s Story: How to Create a $100MM Biopharma Company in Central VA with David Kalergis, CEO
Diffusion’s Story is about strategy, leveraging capital, keeping investors happy, getting the science right and overcoming the challenges of bringing modern medicines to market. Local investor capital, a cool $25MM, raised here in Charlottesville, was key to Diffusion’s success.
At the luncheon, there will be a TV style interactive discussion about ‘Diffusion’s Story” and more.
Bonumose has just filed a patent for low cost manufacture of plant based galactose using its innovative enzymatic technology platform. Dan Wicheleski will be speaking about these latest developments at the Tom Tom Founders Summit Biotechnology Luncheon, Friday April 14.
AMPEL BioSolutions and ArcheMedX Form Partnership Aimed at Improving Success Rate of Clinical Trials
AMPEL BioSolutions, a leading translational medicine and clinical operations company and ArcheMedX, a digital platform for effective online health care education and training programs, today announced a new collaboration to transform clinical trial recruitment and retention by enabling research sites to more effectively educate and continually engage clinical staff and patients.